BERSANI, Giuseppe
 Distribuzione geografica
Continente #
EU - Europa 8.975
NA - Nord America 8.646
AS - Asia 2.059
SA - Sud America 214
OC - Oceania 80
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 3
Totale 20.040
Nazione #
US - Stati Uniti d'America 8.497
IT - Italia 6.567
IN - India 751
SG - Singapore 719
UA - Ucraina 626
FI - Finlandia 385
SE - Svezia 316
CN - Cina 256
FR - Francia 238
GB - Regno Unito 233
DE - Germania 178
AR - Argentina 161
CA - Canada 127
TR - Turchia 97
AU - Australia 68
IE - Irlanda 68
PK - Pakistan 53
RU - Federazione Russa 51
CH - Svizzera 48
ID - Indonesia 43
BG - Bulgaria 36
PH - Filippine 35
NL - Olanda 32
RO - Romania 32
ES - Italia 28
MY - Malesia 28
PL - Polonia 28
BR - Brasile 23
EG - Egitto 21
ZA - Sudafrica 20
CL - Cile 19
IR - Iran 17
BE - Belgio 16
JP - Giappone 16
MX - Messico 15
CZ - Repubblica Ceca 14
NZ - Nuova Zelanda 12
TW - Taiwan 11
GR - Grecia 10
TG - Togo 9
PS - Palestinian Territory 8
PT - Portogallo 8
SV - El Salvador 7
AL - Albania 6
AT - Austria 6
HR - Croazia 6
LT - Lituania 6
CO - Colombia 5
DK - Danimarca 5
EC - Ecuador 5
KR - Corea 5
NG - Nigeria 5
SK - Slovacchia (Repubblica Slovacca) 5
IL - Israele 4
IS - Islanda 4
MD - Moldavia 4
MT - Malta 4
SI - Slovenia 4
EU - Europa 3
HK - Hong Kong 3
KE - Kenya 3
NO - Norvegia 3
GH - Ghana 2
HU - Ungheria 2
LU - Lussemburgo 2
NP - Nepal 2
SA - Arabia Saudita 2
SM - San Marino 2
TH - Thailandia 2
VN - Vietnam 2
AM - Armenia 1
BD - Bangladesh 1
BY - Bielorussia 1
IM - Isola di Man 1
JO - Giordania 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
PE - Perù 1
SC - Seychelles 1
TN - Tunisia 1
Totale 20.040
Città #
Fairfield 959
Chandler 627
Woodbridge 554
Rome 531
Singapore 482
Milan 474
Ann Arbor 432
Houston 423
Ashburn 420
Princeton 390
Plano 363
Wilmington 356
San Paolo di Civitate 316
Seattle 311
Boston 304
Cambridge 281
Jacksonville 183
Lawrence 183
Beijing 162
Federal 149
Millbury 117
San Diego 113
Santa Clara 113
Andover 111
Des Moines 94
Catania 86
Norwalk 84
Naples 76
Toronto 75
Florence 74
Dublin 62
Falls Church 62
Boardman 58
Turin 54
Palermo 53
New York 48
Bari 47
Bologna 41
Padova 39
Helsinki 38
San Mateo 38
Dallas 36
Verona 34
Falkenstein 33
Istanbul 33
Jakarta 33
Torino 30
Napoli 29
Como 25
Southend 24
Bühl 23
London 23
Messina 23
Ankara 21
Moscow 21
Brisbane 20
Mannheim 20
Pisa 20
Bergamo 19
Lahore 19
Sofia 18
Mumbai 17
College Station 16
Mountain View 16
Perugia 16
San Antonio 16
Sandy 16
Dearborn 14
Macerata 14
Pescara 14
Buffalo 13
Karachi 13
Los Angeles 13
Parma 13
Perth 13
La Spezia 12
Latina 12
Monza 12
Nardò 12
Pune 12
Treviso 12
Brussels 11
Burgas 11
Caserta 11
Corato 11
Ottawa 11
Pflugerville 11
Phoenix 11
Redwood City 11
Salerno 11
Vicenza 11
Avellino 10
Aversa 10
Brescia 10
Cagliari 10
Corsico 10
Hefei 10
Lecce 10
Livorno 10
Montreal 10
Totale 10.363
Nome #
La calcificazione della ghiandola pineale e dei plessi corioidei nella schizofrenia: uno studio mediante TAC 5.444
Night Eating Syndrome, circadian rhythms and seasonality. A study in a population of Italian university students 381
Nootropics use in the workplace. Psychiatric and ethical aftermath towards the new frontier of bioengineering 369
Sintomi neurologici associati a sintomi psichiatrici in un caso di cisti aracnoidea 170
Hooked on the mirror: the emergence of exercise addiction, body dysmorphic disorder, and other image-related psychopathological correlates in fitness settings 135
Aspetti descrittivi, demografici e clinici di un campione di pazienti con disturbo dell'adattamento 131
Deep Transcranial Magnetic Stimulation for treatment-resistant bipolar depression: A case report of acute and maintenance efficacy 111
Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects 107
Exploring the relationship between mental wellbeing, exercise routines and the intake of Image and Performance Enhancing Drugs during the COVID-19 pandemic. A comparison across sport disciplines 105
5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with Ritanserin 103
L acetylcarnitine in dysthymic disorder in elderly patients: a double-blind, multicenter, controlled randomized study vs. fluoxetine 99
Studio in doppio cieco della terapia ambulatoriale della Schizofrenia con Trifluperazina versus decanoato di Flufenazina 97
L'adattamento premorboso negli schizofrenici: variabili biologiche, ambientali e caratteriali 97
Cerebral ventricular enlargement and neuroleptic response in chronic schizophrenia: preliminary findings with risperidone 96
25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug 89
Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): A 6-month, open label, follow-up study 89
An association study between schizophrenia and the dopamine receptor genes DRD3 and DRD4 using haplotype relative risk 88
Association of schizophrenia and Carpenter syndrome 88
Cannabis use related to early psychotic onset. Role of premorbid function 87
Potential neuroprotective effect of lithium in bipolar patients evaluated by neuropsychological assessment. Preliminary results 84
The emergence of exercise addiction, body dysmorphic disorder, and other image-related psychopathological correlates in fitness settings. A cross sectional study 83
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 81
Choroid plexus calcification as a possible clue of serotonin implication in schizophrenia 81
A double-blind comparative study of Sertraline and Amitriptyline in outpatients with Major Depressive Episodes 80
Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review 79
Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes 78
Facial expression in patients with bipolar disorder and schizophrenia in response to emotional stimuli: a partially shared cognitive and social deficit of the two disorders. 77
Studio in doppio cieco della Flufenazina decanoato versus placebo nella terapia ambulatoriale di mantenimento di pazienti schizofrenici cronici 76
Demographic variables, clinical aspects, and medicolegal implications in a population of patients with adjustment disorder 76
Effects of treatment with etizolam 0.5 mg BID on cognitive performance: A 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder 76
ETHOLOGICAL PREDICTORS OF AMITRIPTYLINE RESPONSE IN DEPRESSED OUTPATIENTS 75
Combined Serotonin 5-HT2 and Dopamine D2 antagonism in Schizophrenia: clinical, extrapyramidal and neuroendocrine response in a preliminary study with Risperidone (R 64766) 75
New perspectives on techniques for the clinical psychiatrist: Brain stimulation, chronobiology and psychiatric brain imaging 74
5-HT2 antagonist Ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with Orphenadrine and placebo 73
Anomalie di G-6-PD in due soggetti con disturbo schizoide di personalità 72
Captagon. Use and trade in the Middle East 72
Novel psychoactive substances (NPS) use in severe mental illness (SMI) patients. Potential changes in the phenomenology of psychiatric diseases 72
Corticotropin-releasing factor and adrenal function in major depression 70
Adjustment disorders: medico-legal implications in the assessment of biological damage 70
Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms 70
Influence of obstetric complication severity on brain morphology in schizophrenia: an MR study 69
Immediate Serum Growth Hormone Decrease as a Potential Index of Dopamine-Related Response to Electroconvulsive Therapy in Schizophrenic Patients 69
Severity of obstetric complications and risk of adult schizophrenia in male patients: a case-control study 69
Levetiracetam in bipolar spectrum disorders: first evidence of efficacy in an open, add-on study 69
Reduced natural killer cell activity in major depression: neuroendocrine implications 68
The Shanti De Corte case. Euthanasia for mental disorder between clinic and bioethics, between law and medico-legal implications 67
Excess in the spring and deficit in the autumn in birth rates of male schizophrenic patients in Italy: Potential role of perinatal risk factors 67
Deficit of executive functions in schizophrenia: Relationship to neurological soft signs and psychopathology 66
Negative symptoms and visual behavior in DSM III-R prognostic subtypes schizophreniform disorder 66
Neurological soft signs discriminate schizophrenia from bipolar disorder. 66
Reduction of night/day difference in melatonin blood levels as possible disease-related index in schizophrenia 66
The HLA System as a genetic marker of affective disorders: reports on a population from central Italy, with comments on methodology 65
Computed tomography study of pineal calcification in schizophrenia 65
Atypical antipsychotics and polydipsia: a cause or a treatment? 65
Serotonina e depressione: studio multicentrico controllato Tianeptina versus Amitriptilina 65
"Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web. 65
Obstetric complications and neurological soft signs in male patients with schizophrenia 64
Comparison of facial expression in patients with obsessive-compulsive disorder and schizophrenia using the facial action coding system: a preliminary study 64
Facial action coding system (facs): uno strumento di valutazione obiettiva dell’espressività mimica facciale e le sue potenziali applicazioni allo studio della schizofrenia 64
La genetica nei disturbi mentali 64
Exploring the use of Kratom (Mitragyna speciosa) via the YouTube data tool: A novel netnographic analysis 64
Pilot study on light therapy and neurocognitive performance of attention and memory in healthy subjects 62
The prolactin response in patients receiving neuroleptic therapy. The effect of Fluphenazine decanoate 62
Premorbid sleep, appetite, energy, and cognitive circadian profile in patients with depressive disorders 61
Neurological soft signs and cerebral measurements investigated by means of MRI in schizophrenic patients 61
Decision making in mild cognitive impairment: medicolegal implications 61
Negative symptoms as key features of depression among cannabis users: a preliminary report. 60
Schizophrenia and neurogenesis. A stem cell approach 59
Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders 59
Melatonin add-on in manic patients with treatment resistant insomnia 59
Hair analysis for the detection of drug use-is there potential for evasion? 59
Manic-like psychosis associated with elevated trough tacrolimus blood concentrations 17 years after kidney transplant. 58
Changes in dream experience in relation with antidepressant escitalopram treatment in depressed female patients: A preliminary study 57
Accettabilità e sicurezza di impiego della tianeptina nel trattamento della depressione. Studio policentrico a lungo termine 57
Sertraline in the treatment of major depression: an open clinical stratification study in Italian outpatients 56
La legalizzazione della cannabis. Tra irresponsabilità politica e deresponsabilizzazione degli psichiatri 56
Mood disorder in a patient with Smith-Magenis syndrome: A case report 55
Disturbo dell'umore e disturbo esplosivo intermittente in un paziente con sindrome di Smith-Magenis: un caso clinico 55
Lithium from mood stabilizer to putative cognitive enhancer 55
Risk of schizophrenia in male subjects with a history of obstetric complications and their siblings: A controlled study. 55
HLA antigens and neuroleptic response in clinical subtypes of schizophrenia 55
Corpus callosum abnormalities and potential age effect in male schizophrenics: an MRI comparative study 54
The potential role of high or low birthweight as risk factor for adult schizophrenia 53
Brain abnormalities in schizophrenia. A qualitative comparative study of schizophrenic patients and control individuals assessed by magnetic resonance imaging. 53
Generalized and specific emotion impairments as potential markers of severity in obsessive-compulsive disorder. A preliminary study using Facial Action Coding System (FACS) 53
Anamnesi di comportamento aggressivo in pazienti psichiatrici: ruolo di variabili sociodemografiche, familiari, cliniche e cronobiologiche 53
Studio naturalistico sull'impiego degli antipsicotici nella formulazione long acting negli SPDC di Roma e del Lazio 52
Dissociative symptoms in female patients with mood and anxiety disorders: a psychopathological and temperamental investigation. 52
Il PANDAS come possibile modello interpretativo del meccanismo patogenetico del DOC nell'adulto 52
Associazione di epilessia e schizofrenia: studio descrittivo di un campione di pazienti indagato con risonanza magnetica nucleare (RMN) ed elettroencefalografia standard (EEG) 51
Can mobile phone technology support a rapid sharing of information on novel psychoactive substances among health and other professionals internationally? 51
Manifesto for a European research network into obsessive-compulsive and related disorders. 50
Changes in impulse control disorder features in a present kleptomania patient and importance of rational treatment strategy on social dangerousness. a case report 49
Neurological Soft Signs in schizophrenic patients treated with conventional and atypical antipsychotics 49
Intimate Female Partner Homicide Suicide. Demographic and psychopathology aspects of perpetrators and a potential not yet classified diagnostic entityAnalyses of data taken from newspapers in Italy from 2009 to 2019 48
Olfactory identification deficits and associated response inhibition in obsessive-compulsive disorder: On the scent of the orbitofronto-striatal model 48
Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders 48
Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psycopathology 48
Valutazioni morfofunzionali cerebrali e trattamento farmacologico in un caso clinico di schizofrenia con polidipsia 47
Omosexual parents. Does a need exist for a reflection by mental health experts? 47
Totale 12.987
Categoria #
all - tutte 51.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 439
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.089


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.475 0 0 0 0 0 211 220 275 203 249 163 154
2020/20211.683 154 160 129 157 105 98 105 170 147 243 146 69
2021/20223.900 86 293 322 246 476 91 94 416 361 354 343 818
2022/20233.576 721 668 191 232 366 379 111 245 290 111 168 94
2023/20242.860 194 275 161 255 200 211 112 151 62 430 382 427
2024/20251.645 308 164 298 295 300 280 0 0 0 0 0 0
Totale 20.401